Research Skills Medical Student Journal Club - November (Cancer Clinical Trials)

Name: Research Skills Medical Student Journal Club - November (Cancer Clinical Trials)
Start: 2024-11-13T19:00:00+00:00
End: 2024-11-13T20:00:00+00:00

13th Nov 2024

7:00 - 8:00pm (GMT)

13th Nov 2024

7:00 - 8:00pm (GMT)

Hosted on MedAll

Attendance certificate available

This event has ended. Similar events

Free

ONLINE

Catch-up content

Description

Looking to sharpen your critical appraisal skills in a fun and supportive space? Our monthly journal club is the perfect place for you - no research experience required.

Theme of the month: Clinical trials in oncology

Paper this month: Combining pembrolizumab and chemotherapy vs placebo and chemotherapy for first time treatment of advanced triple-negative breast cancer: KEYNOTE-355 trial results

Session structure:

20 minute presentation of a clinical trial paper by David Withey, 4th year medical student with a PhD in Cancer Sciences
Group discussion of the paper
Introduction to critical appraisal and randomised controlled trials

Summary

The November session of our Research Skills Medical Student Journal Club focuses on cancer clinical trials. Perfect for anybody looking to fine-tune their critical appraisal skills in an enjoyable, supportive setting and requires no prior research experience. The topic for discussion is the combination of pembrolizumab and chemotherapy versus placebo and chemotherapy shown in the KEYNOTE-355 trial results. The session starts with a 20-min presentation by David Withey, a 4th-year medical student, with a Cancer Sciences PhD, followed by a group discussion and an introduction to critical appraisal and randomised controlled trials.

Generated by MedBot

Learning objectives

To understand and interpret the results of the KEYNOTE-355 clinical trial on the treatment of advanced triple-negative breast cancer.
To develop and strengthen skills pertaining to critical appraisal, specifically in the context of clinical trials in oncology.
To enhance knowledge about the process and methodologies behind randomized controlled trials in the medical field.
To foster active participation in in-depth group discussions about oncology clinical trials and develop collaborative learning skills.
To comprehend the importance and impact of combining therapies such as pembrolizumab and chemotherapy in oncology clinical trials.

Generated by MedBot

57 people attended this event. Sign up today and join your colleagues at future events.

Speaking at this event

View all